INS and type 1 diabetes mellitus: It has been thought that metformin or metformin + vildagliptin therapy led to inflammation or insulin therapy resulted in an antiinflammatory effect in such a way that T1DM patients presented lower neopterin levels compared to control lacking statistical significance.